| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.003 | 1 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |